会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • APO A-I MIMETIC PEPTIDES AND METHODS OF TREATMENT
    • APO A-I MIME技术和治疗方法
    • US20110263497A1
    • 2011-10-27
    • US13177473
    • 2011-07-06
    • Katsuyuki MuraseLi ZhaoIrina AstafievaPaul M. Consigny
    • Katsuyuki MuraseLi ZhaoIrina AstafievaPaul M. Consigny
    • A61K38/10A61P9/10
    • A61K38/17A61K31/661A61K38/10A61K38/1709
    • A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a synthetic apolipoprotein A-1 (Apo A-I) mimetic peptide into a wall of the blood vessel at the particular region, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including a synthetic apolipoprotein A-I (Apo A-I) mimetic peptide, or combination of an Apo A-I synthetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of an endogenous Apo A-I related peptide. A composition including an apolipoprotein A-1 (Apo A-I) synthetic peptide in a form suitable for delivery into a blood vessel, the peptide including an amino acid backbone that has less amino acid residues relative to endogenous Apo A-I and a chimera of helix 1 and helix 9 of Apo A-I.
    • 一种方法,包括使输送装置通过血管的内腔前进到血管中的特定区域; 并将合成的载脂蛋白A-1(Apo A-I)模拟肽引入特定区域的血管壁,其中该肽具有使肽在反向胆固醇转运中有效的性质。 包含合适的载脂蛋白AI(Apo AI)模拟肽或Apo AI合成肽和Acyl CoA胆固醇:酰基转移酶(ACAT)抑制剂的组合的组合物,其形式适于递送到血管中,所述肽包含氨基酸 序列以与内源性Apo AI相关肽的顺序相反的顺序。 一种组合物,其包含适于递送至血管的形式的载脂蛋白A-1(Apo AI)合成肽,所述肽包含相对于内源性Apo AI具有较少氨基酸残基的氨基酸主链和螺旋1的嵌合体, Apo AI的螺旋9。